Literature DB >> 20089616

Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.

Gregorio Chazenbalk1, Bradley S Trivax, Bulent O Yildiz, Cristina Bertolotto, Ruchi Mathur, Saleh Heneidi, Ricardo Azziz.   

Abstract

CONTEXT: Adipose tissue dysfunction associated with low-grade chronic inflammation and dysregulation of adipokine secretion might significantly contribute to the pathogenesis of polycystic ovary syndrome (PCOS).
OBJECTIVE: The objective of the study was to determine whether the effect of TNF-alpha, IL-6, monocyte chemoattractant protein-1, or coculture of adipocytes and adipose tissue macrophages (ATMs), on the secretion of adiponectin by adipocytes, differs in PCOS compared with controls. DESIGN AND PARTICIPANTS: Primary cultures of sc adipocytes and coculture of adipocytes and ATMs from overweight and obese patients with PCOS and healthy control women were used. MAIN OUTCOME MEASURES: Adiponectin secretion by adipocytes was measured.
RESULTS: The baseline secretion of adiponectin by isolated adipocytes did not differ between PCOS and control samples. The net change in adiponectin secretion in response to IL-6, monocyte chemoattractant protein-1, and TNF-alpha differed between PCOS (decreasing) and control (increasing) adipocytes, although the difference reached significance only for TNF-alpha (P < 0.04). Coculture of isolated adipocytes and ATMs resulted in a decrease in adiponectin secretion by PCOS (P < 0.05) but not control adipocytes, and the difference between the net change in adiponectin secretion in PCOS vs. control samples was significant (P < 0.03).
CONCLUSIONS: Our results suggest that adiponectin secretion by adipocytes in response to cytokines/chemokines and most notably in response to coculturing with ATMs differs between PCOS and control women, favoring greater suppression of adiponectin in PCOS. The mechanisms underlying these defects and the role of concurrent obesity remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089616      PMCID: PMC2840865          DOI: 10.1210/jc.2009-1158

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  47 in total

Review 1.  Adipose tissue as an endocrine organ.

Authors:  R S Ahima; J S Flier
Journal:  Trends Endocrinol Metab       Date:  2000-10       Impact factor: 12.015

2.  NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes.

Authors:  Hyun Bae Kim; Minyoung Kong; Tae Min Kim; Young Ho Suh; Won-Ho Kim; Joo Hyun Lim; Ji Hyun Song; Myeong Ho Jung
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

3.  [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].

Authors:  Wei-hong Hu; Jie Qiao; Shu-yun Zhao; Xiao-wei Zhang; Mei-zhi Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2006-10-18

4.  Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.

Authors:  Alexandros N Vgontzas; Georgia Trakada; Edward O Bixler; Hung-Mo Lin; Slobodanka Pejovic; Emmanuel Zoumakis; George P Chrousos; Richard S Legro
Journal:  Metabolism       Date:  2006-08       Impact factor: 8.694

5.  Diagnostic criteria for polycystic ovary syndrome: a reappraisal.

Authors:  Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

Review 6.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

7.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

8.  Hirsutism: implications, etiology, and management.

Authors:  R Hatch; R L Rosenfield; M H Kim; D Tredway
Journal:  Am J Obstet Gynecol       Date:  1981-08-01       Impact factor: 8.661

9.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

10.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  15 in total

1.  Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.

Authors:  Gregorio Chazenbalk; Yen-Hao Chen; Saleh Heneidi; Jung-Min Lee; Marita Pall; Yii-Der Ida Chen; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2012-02-16       Impact factor: 5.958

2.  Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.

Authors:  Uche Ezeh; Ida Y-D Chen; Yen-Hao Chen; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

Review 3.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

Review 4.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

5.  A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.

Authors:  T Kume; M Calan; O Yilmaz; G U Kocabas; P Yesil; M Temur; M Bicer; O G Calan
Journal:  J Endocrinol Invest       Date:  2016-03-11       Impact factor: 4.256

Review 6.  Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity.

Authors:  Miki Okada-Iwabu; Masato Iwabu; Toshimasa Yamauchi; Takashi Kadowaki
Journal:  Diabetol Int       Date:  2019-09-19

7.  Association of SNPs in the FK-506 binding protein (FKBP5) gene among Han Chinese women with polycystic ovary syndrome.

Authors:  Xinyue Ma; Zhao Wang; Changming Zhang; Yuehong Bian; Xin Zhang; Xin Liu; Yongzhi Cao; Yueran Zhao
Journal:  BMC Med Genomics       Date:  2022-07-04       Impact factor: 3.622

8.  Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Ricardo Azziz
Journal:  Hum Reprod       Date:  2014-05-09       Impact factor: 6.918

9.  Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Damini Dey; Daniel Berman; Ida Y Chen; Daniel A Dumesic; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

Review 10.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.